Welcome to our dedicated page for Clean Energy Fuels SEC filings (Ticker: CLNE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Clean Energy Fuels Corp. filings document financial results, governance, and public-company disclosures for a renewable natural gas transportation-fuel provider. Form 8-K reports furnish quarterly and annual operating results, RNG gallons sold, station construction revenue, RIN and LCFS credit revenue, and warrant-related revenue effects tied to reported results.
Proxy materials cover board elections, executive compensation, equity awards, pay-versus-performance disclosure, and shareholder voting matters. Other current reports record officer and director appointments or resignations, compensatory arrangements, and related governance changes for the Nasdaq-listed company.
Clean Energy Fuels Corp. director and CEO Andrew J. Littlefair reported the sale of 250,000 shares of the company's common stock on 08/14/2025 at a weighted average price of $2.25 per share, with individual sale prices ranging from $2.20 to $2.28. After the reported disposition, Mr. Littlefair beneficially owns 1,494,637 shares, held directly. The sale was signed on behalf of Mr. Littlefair by an attorney-in-fact on 08/15/2025. The filing notes the reporting person will provide granular pricing details on request. No derivative transactions or other securities classes are reported in this Form 4.
Clean Energy Fuels Corp. (CLNE) filing a Form 144 notifies the market of a proposed sale of 250,000 common shares through Raymond James & Associates on 08/14/2025, with an aggregate market value of $562,500.00. The filing details that the shares were originally acquired primarily through RSU vesting on multiple dates between 2014 and 2023. The filer reports no securities sold in the past three months. The notice includes the standard attestation that the selling person is not aware of undisclosed material adverse information. The proposed sale represents approximately 0.114% of the 219,289,216 shares outstanding disclosed in the form.